The Financial Toxicity of Cancer: Proposed Solutions and Resources
Some of the ways that policy makers, medical providers and patients can reduce the financial toxicity of cancer treatment.
Charity Review: Cancer Research Institute
The Cancer Research Institute fosters research in cancer immunology to develop more effective life-saving treatments for all types of cancer.
A Role for Progesterone in Breast Cancer Treatment?
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
5 Cancer Research Stories Worth Following – Spring 2017
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
What is “Step Therapy” and Why Should We Care?
How is the practice of “step therapy” affecting patients?
Review of “The Gene: An Intimate History” by Siddhartha Mukherjee
In the next decade, we’re likely to know much more about our individual risks for a variety of diseases and conditions based on the information contained in our genomes.
5 Cancer Research Stories Worth Following – Winter 2017
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
A New Year: Where Do We Go From Here?
Let’s keep moving forward in 2017 and address health care access issues, including out-of-pocket costs, that are priorities for most Americans.
10 Things We Learned About Progress Against Cancer in 2016
Prominent issues in cancer research this year included finding ways to make immune system therapies safer and effective for more patients, and the need to make new cancer medicines more affordable.
Cancer and Health Policy: Some Things I’m Watching
Possible health policy changes in the coming months could be critical for anyone affected by or potentially affected by cancer.
5 Cancer Research Stories Worth Following – Fall 2016
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.
